The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Cohen, Ezra
Item TypeName
Concept Proto-Oncogene Proteins
Concept Proto-Oncogene Proteins B-raf
Concept Proto-Oncogene Proteins c-kit
Concept Proto-Oncogene Proteins c-ret
Concept Proto-Oncogene Proteins p21(ras)
Concept Proto-Oncogene Proteins c-met
Concept Proto-Oncogenes
Concept Proto-Oncogene Proteins c-akt
Academic Article A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer.
Academic Article The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.
Academic Article Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer.
Academic Article Efficacy of the multi-kinase inhibitor enzastaurin is dependent on cellular signaling context.
Academic Article Detection of tumor epidermal growth factor receptor pathway dependence by serum mass spectrometry in cancer patients.
Academic Article New approaches to thyroid cancer.
Academic Article Novel molecular targeted therapies for refractory thyroid cancer.
Academic Article Molecular phenotype predicts sensitivity of squamous cell carcinoma of the head and neck to epidermal growth factor receptor inhibition.
Academic Article Phase II efficacy and pharmacogenomic study of Selumetinib (AZD6244; ARRY-142886) in iodine-131 refractory papillary thyroid carcinoma with or without follicular elements.
Academic Article Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck.
Academic Article A phase Ib trial of LY2584702 tosylate, a p70 S6 inhibitor, in combination with erlotinib or everolimus in patients with solid tumours.
Academic Article p62/SQSTM1 accumulation in squamous cell carcinoma of head and neck predicts sensitivity to phosphatidylinositol 3-kinase pathway inhibitors.
Academic Article Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors.
Academic Article Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial.
Academic Article Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.
Academic Article PI3K? is a molecular switch that controls immune suppression.
Academic Article Correlative analyses of RET and RAS mutations in a phase 3 trial of cabozantinib in patients with progressive, metastatic medullary thyroid cancer.
Academic Article Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer.
Search Criteria
  • Proto Oncogenes